Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Many patients are looking for ways to go beyond reactive care and take a more proactive approach to how they feel and function
Large trials of dulaglutide, for example, showed cardiovascular benefit in type 2 diabetes [7]
The earliest it could hit the market would be late 2026, though it's more likely to drop in 2027
That is, compared to insulin, 57 and 30 patients would need to be treated with a GLP-1RA for a mean of 2.3 years to prevent one case of all-cause mortality and hospitalized hypoglycemia, respectively, which would cost US$54,851 and US$29,115 per case of all-cause mortality and hospitalized hypoglycemia prevented, respectively, from the payer perspective, and would save US$19,391 and US$10,293, respectively, from the healthcare sector perspective
Methamphetamine use may induce the following physical effects: anorexia, hyperactivity, dilated pupils, flushing, restlessness, dry mouth, bruxism, headache, cardiovascular alterations in heart rate, and blood pressure
